Merck paid Elsevier an undisclosed sum to produce several volumes of the Australasian Journal of Bone and Joint Medicine, which might be mistaken for a peer reviewed journal, the Scientist reports. However, it contained only reprinted articles that seemed to act solely as marketing tools, with no disclosure of company sponsorship. The journal was not indexed in Medline and carried advertisements for the Merck drugs Fosamax and Vioxx. A spokesperson for Elsevier told the Scientist, "I wish there was greater disclosure that it was a sponsored journal." (www.the-scientist.com/blog/display/55671/)
Comments